Oral RNA

Unlocking Oral RNA Therapeutics: Overcoming Barriers to Gut-Stable Delivery

David Alvaro, Ph.D.

Pharma's Almanac

IBD

Glycocaging: A Smart Chemistry Platform for Safer, Smarter IBD Treatments

David Alvaro, Ph.D.

Pharma's Almanac

Recruitment

Bringing Clinical Trial Enrollment to the Point of Diagnosis

Tim Rich; Matt Schwartz

PPD clinical research business of Thermo Fisher Scientific

Tissue Models

Exploring Pharmacokinetics and Safety for Drugs Targeting the Gut

Altis Biosystems

Tissue Models

Accurately Recapitulating Environmental Niches in In Vitro Models of the Intestine

Liz Boazak, Ph.D.

Altis Biosystems

Tissue Models

Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity

Ron Laethem, Ph.D.

Altis Biosystems

Tissue Models

Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro

Bailey Zwarycz, Ph.D

Altis Biosystems

Tissue Models

The Power of RepliGut In Vitro Intestinal Stem Cell Models

Bailey Zwarycz, Ph.D

Altis Biosystems

Preclinical

Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells

Ron Laethem, Ph.D.

Altis Biosystems

The Future of Healthcare

How Does Altis Biosystems Envision the Future of the Pharma/Biopharma Industry?

Altis Biosystems

Microbiome

Evaluating Microbiome Therapies with Intestinal Cell Models

Scott Magness, Ph.D.

Altis Biosystems

Microphysiological Systems

Accelerating Drug Development with Microphysiological Systems (MPS)

Nancy Allbritton, Ph.D., M.D.

Altis Biosystems